Articles

Subcategories

12 Jun 2012 Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
11 Jun 2012 Grifols Publishes Positive Phase I Safety Results for Plasmin, a Novel, Direct-Acting Thrombolytic, in the Journal of Thrombosis and Haemostasis
11 Jun 2012 A new study with 'real world' data shows greater efficacy of Victoza(R), with weight loss and cost-effectiveness, in type 2 diabetes compared to twice-daily exenatide and DPP-4 inhibitors
11 Jun 2012 Investigational ultra-long-acting insulin degludec reduces rates of nocturnal hypoglycaemia in type 2 diabetes patients versus insulin glargine (9 Jun 2012)
11 Jun 2012 Lantus(R) Initiation After Metformin Achieved Superior Glycemic Control Versus Sitagliptin in Type 2 Diabetes
11 Jun 2012 Halozyme Presents Positive Data from Two Ultrafast Insulin Clinical Trials with Human Hyaluronidase Enzyme - rHuPH20 - at ADA 2012
11 Jun 2012 BYDUREON Was Associated with Significant and Sustained Glycemic Control at Four Years
11 Jun 2012 SYMLIN Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
11 Jun 2012 Once-Weekly BYDUREON Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir in Type 2 Diabetes

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top